Editorial
Incorporating New Therapy Into Established Clinical Practice Guidelines
In this issue of the Southern Medical Journal, McFarland et al have published a quite interesting article entitled “Place in Therapy for Liraglutide and Saxagliptin for Type 2 Diabetes.”1 The authors describe and discuss the pharmacology and the utilization for these unique anti-diabetic drugs. Liraglutide, like exenatide, is a glucagon-like…